We are investigating Vital Therapies, Inc. (NasdaqGS: VTL) and its Board of Directors for potential federal law violations and/or breaches of fiduciary duties in connection with the acquisition of Immunic AG for approximately 735 shares of Vital Therapies common stock for each share of Immunic.